BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Said A. Non-alcoholic fatty liver disease and liver transplantation: Outcomes and advances. World J Gastroenterol 2013; 19(48): 9146-9155 [PMID: 24409043 DOI: 10.3748/wjg.v19.i48.9146]
URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9146.htm
Number Citing Articles
1
Hyeyoung Kim, Kwang‐Woong Lee, Kyoungbun Lee, Sooin Seo, Min‐Young Park, Sung Woo Ahn, Suk Kyun Hong, Kyung Chul Yoon, Hyo‐Sin Kim, YoungRok Choi, Hae Won Lee, Nam‐Joon Yi, Kyung‐Suk Suh. Effect of PNPLA3 I148M polymorphism on histologically proven non‐alcoholic fatty liver disease in liver transplant recipientsHepatology Research 2018; 48(3) doi: 10.1111/hepr.12940
2
H. Jin, X. Xu, B. Pang, R. Yang, H. Sun, C. Jiang, D. Shao, J. Shi. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysisBeneficial Microbes 2021; 12(6): 517 doi: 10.3920/BM2020.0183
3
Samer Gawrieh. Liver Disorders2017; : 199 doi: 10.1007/978-3-319-30103-7_14
4
Jeong Hee Yoon, Jeong Min Lee, Kyung-Suk Suh, Kwan-Woong Lee, Nam-Joon Yi, Kyung Bun Lee, Joon Koo Han, Byung Ihn Choi. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?Radiology 2015; 276(2): 453 doi: 10.1148/radiol.15140908
5
Sarina Pasricha, Jane Kenney-Hunt, Kristy Anderson, Nadereh Jafari, Rabea A Hall, Frank Lammert, James Cheverud, Richard M Green. Identification of eQTLs for Hepatic Xbp1s and Socs3 Gene Expression in Mice Fed a High-Fat, High-Caloric DietG3 Genes|Genomes|Genetics 2015; 5(4): 487 doi: 10.1534/g3.115.016626
6
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver TransplantGastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
7
Ravikiran S. Karnam, Gopika Punchhi, Nicholas Mitsakakis, Shiyi Chen, Giovanna Saracino, Leslie Lilly, Sumeet K. Asrani, Mamatha Bhat. Predicting the outcome of liver transplantation in patients with non‐alcoholic steatohepatitis cirrhosis: The NASH LT risk‐benefit calculatorClinical Transplantation 2023; 37(4) doi: 10.1111/ctr.14930
8
G. Losurdo, A. Castellaneta, M. Rendina, S. Carparelli, G. Leandro, A. Di Leo. Systematic review with meta‐analysis: de novo non‐alcoholic fatty liver disease in liver‐transplanted patientsAlimentary Pharmacology & Therapeutics 2018; 47(6): 704 doi: 10.1111/apt.14521
9
Varun Saxena, Norah A. Terrault. Zakim and Boyer's Hepatology2018; : 784 doi: 10.1016/B978-0-323-37591-7.00053-7
10
Hunter B. Moore, Yanik J. Bababekov, James J. Pomposelli, Megan A. Adams, Cara Crouch, Dor Yoeli, Rashikh A. Choudhury, Tanner Ferrell, James R. Burton, Elizabeth A. Pomfret, Trevor L. Nydam. The vexing triad of obesity, alcohol, and coagulopathy predicts the need for multiple operations in liver transplantationThe American Journal of Surgery 2022; 224(1): 69 doi: 10.1016/j.amjsurg.2022.02.053
11
Jennifer E. Lambert, Jill A. Parnell, Bertus Eksteen, Maitreyi Raman, Marc R. Bomhof, Kevin P. Rioux, Karen L. Madsen, Raylene A. Reimer. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocolBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0400-5
12
Giuseppina Pisano, Anna L Fracanzani, Lucio Caccamo, Maria F Donato, Silvia Fargion. Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective studyWorld Journal of Gastroenterology 2016; 22(40): 8869-8882 doi: 10.3748/wjg.v22.i40.8869
13
Ivana Mikolasevic, Lidija Orlic, Irena Hrstic, Sandra Milic. Metabolic syndrome and non‐alcoholic fatty liver disease after liver or kidney transplantationHepatology Research 2016; 46(9): 841 doi: 10.1111/hepr.12642
14
Hao-Jun Yang, Li-Ming Tang, Xian-Ju Zhou, Jun Qian, Jie Zhu, Ling Lu, Xue-Hao Wang. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in miceHepatobiliary & Pancreatic Diseases International 2015; 14(6): 619 doi: 10.1016/S1499-3872(15)60361-7
15
Samer Gawrieh, Naga Chalasani. Alcoholic and Non-Alcoholic Fatty Liver Disease2016; : 313 doi: 10.1007/978-3-319-20538-0_16
16
Suliman Al Humayed. Protective and therapeutic effects ofCrataegus aroniain non-alcoholic fatty liver diseaseArchives of Physiology and Biochemistry 2017; 123(1): 23 doi: 10.1080/13813455.2016.1205097
17
Kareem Hassan, Varun Bhalla, Mohammed Ezz El Regal, H Hesham A-Kader. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemicWorld Journal of Gastroenterology 2014; 20(34): 12082-12101 doi: 10.3748/wjg.v20.i34.12082
18
Xuanfei Li, Yakun Wu, Wenfeng Zhang, Jianping Gong, Yao Cheng. Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cellsBiomedicine & Pharmacotherapy 2017; 89: 1392 doi: 10.1016/j.biopha.2017.03.022
19
Raquel G. Bardallo, Rui Teixeira da Silva, Teresa Carbonell, Emma Folch-Puy, Carlos Palmeira, Joan Roselló-Catafau, Jacques Pirenne, René Adam, Arnau Panisello-Roselló. Role of PEG35, Mitochondrial ALDH2, and Glutathione in Cold Fatty Liver Graft Preservation: An IGL-2 ApproachInternational Journal of Molecular Sciences 2021; 22(10): 5332 doi: 10.3390/ijms22105332
20
Conor P. Woods, Jonathon M. Hazlehurst, Jeremy W. Tomlinson. Glucocorticoids and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology 2015; 154: 94 doi: 10.1016/j.jsbmb.2015.07.020
21
Shuqian Wan, Long Zhang, Yunyun Quan, Kun Wei. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapyRoyal Society Open Science 2018; 5(11): 181457 doi: 10.1098/rsos.181457
22
Alabagi Abdulla, Charity Reynolds, H Hesham A-Kader. Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a CureEuropean Medical Journal 2016; : 93 doi: 10.33590/emj/10314771
23
Xu Liu, Ayako Hakucho, Jinyao Liu, Tatsuya Fujimiya. Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resectionWorld Journal of Gastroenterology 2014; 20(48): 18249-18259 doi: 10.3748/wjg.v20.i48.18249
24
Maura O’Neil, Ivan Damjanov, Ryan M. Taylor. Liver Pathology for Clinicians2015; : 123 doi: 10.1007/978-3-319-20080-4_7
25
Qing Pang, Jing-Yao Zhang, Si-Dong Song, Kai Qu, Xin-Sen Xu, Su-Shun Liu, Chang Liu. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass indexWorld Journal of Gastroenterology 2015; 21(5): 1650-1662 doi: 10.3748/wjg.v21.i5.1650
26
Antônio R. Andrade, Paulo L. Bittencourt, Liana Codes, Maria A. Evangelista, Alessandra O. Castro, Ney Boa Sorte, Carolina G. Almeida, Jorge A. Bastos, Helma P. Cotrim. New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver TransplantationAnnals of Hepatology 2017; 16(6): 932 doi: 10.5604/01.3001.0010.5285